Closing Bell Roundup

Cloud Earnings Impress, Diabetes Devices Gain Ground, and a Trial Miss Sinks Biotech

Earnings beats lift tech and devices, while a trial miss sinks biotech shares.

A Site Expansion Fuels Breakout, Fintech Turns Profitable, and EV Write-Downs Shake Earnings

Expansion and profits lift winners, while EV write-downs spark a sharp sell-off.

Oncology Funding Ignites, EU Approval Expands Reach, and Tech Volatility Pressures Chips

Chip-Tech Momentum Builds, Buyout Premium Lifts Stock, and Dilution Fears Hit Construction

AI tech rallies, a buyout pays up, but dilution fears sink one stock.

Engineered Crops Break Out, Gaming Margins Expand, and an AI Debut Stumbles

Ag-tech and gaming rally, while an AI debut stumbles on its first day.

Cloud and Laser Earnings Shine, Machine Vision Finds Momentum, and a Biotech Pivot Shakes Confidence

Cloud and industrial earnings surge, while a biotech reset shakes investor confidence.